Allos Therapeutics' IPO

Allos Therapeutics raised a round of funding on March 17, 2000. Investors include Public.

Allos Therapeutics is a biopharmaceutical company focused on developing and commercializing small molecule drugs for the treatment of cancer. The Company's lead product candidate, pralatrexate (PDX) i…

Articles about Allos Therapeutics' IPO: